SCHEMBL16865406

SCHEMBL16865406

CCCC[S+]([O-])C1(Cc2ccccc2)C(=O)N(C)C(=O)N(c2ccccc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 7/20 0.50
SMN1; SMN2 Q16637 4/20 0.37
LMNA P02545 3/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
CNR1 P21554 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16865407 0.71 ELANE (0.54) ELANENPSR1ALDH1A1CYP1A2CYP3A4
SCHEMBL16867610 0.70 ELANE (0.46) ELANESMN1; SMN2LMNAHTTMEN1
SCHEMBL16867611 0.69 ELANE (0.51) ELANENPSR1ALDH1A1CYP1A2CYP3A4
SCHEMBL16865420 0.69 ELANE (0.54) ELANEOPRM1OPRL1NPSR1ALDH1A1
SCHEMBL4428745 0.68 ELANE (0.74) ELANENPSR1ALDH1A1CYP1A2CYP3A4
SCHEMBL16865451 0.67 ELANE (0.51) ELANENPSR1ALDH1A1CYP1A2CYP3A4
SCHEMBL13879387 0.67 ELANE (0.59) ELANESMN1; SMN2LMNAHTTMEN1
SCHEMBL17716270 0.64 ELANE (0.87) ELANENPSR1ALDH1A1CYP1A2CYP3A4
SCHEMBL16865402 0.64 ELANE (0.48) ELANELMNAMEN1KMT2AALDH1A1
SCHEMBL9726893 0.64 ELANE (0.49) ELANESMN1; SMN2LMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150185368-A1 OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME, AND COMPOUND FUJIFILM CORPORATION (JP) 2015-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150185368-A1 OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME, AND COMPOUND C1R, C1S, C3AR1 ELANE 2715/4885SMN1; SMN2 4738/4885LMNA 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.